Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2013
06/25/2013US8470868 Formulation for the prevention of cardiovascular disease
06/25/2013US8470865 Methods and compositions for increasing the anaerobic working capacity in tissues
06/25/2013US8470798 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
06/25/2013US8470797 Inducible small RNA expression constructs for targeted gene silencing
06/25/2013US8470796 Treatment of cancer by inhibition of IGFBPs and clusterin
06/25/2013US8470785 Method for treating ocular cancer
06/25/2013US8470784 Methods and compositions for preventing or treating ophthalmic conditions
06/25/2013US8470783 For treating prostate cancer and malignant lymphoma; gene expression inhibition
06/25/2013US8470782 Transglutaminase inhibitors and methods of use thereof
06/25/2013US8470780 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
06/25/2013US8470779 Catecholamine regulated protein
06/25/2013US8470778 VIP fragments and methods of use
06/25/2013US8470777 Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin
06/25/2013US8470776 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
06/25/2013US8470775 Compositions and methods for reducing the risk of preeclampsia
06/25/2013US8470774 Deoxycorticosterone induced elastin production
06/25/2013US8470772 Leptin agonist and methods of use
06/25/2013US8470771 Method and medicament for inhibiting the infection of influenza virus
06/25/2013US8470770 Antimicrobial agents
06/25/2013US8470769 Method of treatment of bacterial infection by administration of poly-lysine
06/25/2013US8470768 Peptide epitopes of apolipoprotein B
06/25/2013US8470767 Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
06/25/2013US8470766 Protein kinase C therapy for the treatment of acute lung injury
06/25/2013US8470603 Methods of evaluating diethylamide in glatiramer acetate
06/25/2013US8470597 Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof
06/25/2013US8470562 IRX-2 modified manufacturing process
06/25/2013US8470559 Growth hormone fusion proteins
06/25/2013US8470545 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
06/25/2013US8470527 Method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives with enhanced pharmacological properties
06/25/2013US8470371 Polymeric micellar clusters and their uses in formulating drugs
06/25/2013US8470370 Controlled release formulations
06/25/2013US8470358 Nitric oxide generating medical devices
06/25/2013US8470354 Osteogenic implants with combined implant materials and methods for same
06/25/2013US8470340 Peptides presenting an epitope of a domain of factor H binding protein and methods of use
06/25/2013US8470337 Therapeutic treatments using botulinum neurotoxin
06/25/2013US8470334 Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics
06/25/2013US8470332 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
06/25/2013US8470330 PSMA antibodies and uses thereof
06/25/2013US8470317 B7RP-1 antagonists
06/25/2013US8470315 Non-natural ribonuclease conjugates as cytotoxic agents
06/25/2013US8470307 Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
06/25/2013US8470295 Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs
06/25/2013DE202013004047U1 Infusionslösung Solution for infusion
06/25/2013DE202010017989U1 Stabilisiertes immunkorrigierendes Heilmittel zur Behandlung von infektiös-entzündlichen Erkrankungen Stabilized immune corrective remedies for the treatment of infectious-inflammatory diseases
06/25/2013CA2653566C Compounds and methods for immunotherapy and diagnosis of tuberculosis
06/25/2013CA2633074C Elongase genes and uses thereof
06/25/2013CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
06/25/2013CA2545255C Interleukin-10 antibodies
06/25/2013CA2513743C Reducing culling in herd animals growth hormone releasing hormone (ghrh)
06/25/2013CA2513218C Peptides and uses thereof for preventing and treating alzheimer's disease(ad)
06/25/2013CA2506218C Use of plasma proteins concentrates containing vwf with a high proportion of high molecular weight multimers
06/25/2013CA2496422C Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
06/25/2013CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
06/25/2013CA2480217C G-type peptides to ameliorate atherosclerosis
06/25/2013CA2454578C Modified human thymic stromal lymphopoietin
06/25/2013CA2328520C Use of anti-prolactin agents to treat proliferative conditions
06/25/2013CA2313169C Engraftable neural progenitor and stem cells for brain tumor therapy
06/25/2013CA2214453C Novel avian cytokines and genetic sequences encoding same
06/20/2013WO2013090858A2 Oxygenation of the mucosal barrier by enteral artificial blood to prevent hypoxic breakdown of the mucosal barrier
06/20/2013WO2013090833A1 Angiotensins for treatment of fibrosis
06/20/2013WO2013090770A2 Delivery of therapeutic agents by a collagen binding protein
06/20/2013WO2013090552A1 Compositions and methods for reducing ctl exhaustion
06/20/2013WO2013090205A2 Methods for use of neural stem cell compositions for treatment of central nervous system lesions
06/20/2013WO2013089835A1 Composition and method for treating nucleic acid-related eye disease
06/20/2013WO2013089832A1 Modulation of thymosin beta-4 in skin
06/20/2013WO2013089808A1 Decellularized small particle tissue
06/20/2013WO2013089491A1 Multiblock-copolymer aqueous solution composition with improved-stability
06/20/2013WO2013089152A1 Lipid nanoparticles containing combinations of cationic lipids
06/20/2013WO2013089151A1 Lipid nanoparticles for drug delivery system containing cationic lipids
06/20/2013WO2013088395A1 Clicked somatostatin conjugated analogs for biological applications
06/20/2013WO2013088382A1 Therapy for subarachnoid hemorrhage and ischemia
06/20/2013WO2013088371A2 Use of the mmp-12 protein in the prevention and/or treatment of dandruff conditions of the scalp
06/20/2013WO2013088370A2 Use of the protein mmp-12 in the prevention and/or treatment of sensitive skin
06/20/2013WO2013088369A2 Use of the protein mmp-12 in the prevention and/or treatment of greasy skin and/or greasy-prone skin
06/20/2013WO2013088368A2 Use of the mmp-12 protein in the prevention and/or treatment of aged or senescent skin
06/20/2013WO2013088241A1 Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
06/20/2013WO2013088194A1 Modified peptides and their use for treating autoimmune diseases
06/20/2013WO2013088191A1 Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
06/20/2013WO2013087936A1 Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders
06/20/2013WO2013087837A1 Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
06/20/2013WO2013087743A1 Inhibitors of hcv ns5a
06/20/2013WO2013087727A1 New efficient interferon-based treating methods
06/20/2013WO2013087725A1 Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
06/20/2013WO2013087660A1 Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
06/20/2013WO2013087119A1 Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
06/20/2013WO2013087043A1 Flavobacterium strain, endo-alginate lyase encoding gene, and preparation and use of said gene
06/20/2013WO2013086927A1 Human insulin analogue and acylated derivative thereof
06/20/2013WO2013086786A1 Compound and composition having hypoglycemic effect and use thereof
06/20/2013WO2013086785A1 Compound and composition having hypoglycemic effect and use thereof
06/20/2013WO2013073968A3 Agents for modulation of cell signalling
06/20/2013WO2013063383A3 Vectors encoding rod-derived cone viability factor
06/20/2013WO2013058640A3 Method for the extraction, verification and counting of dialyzed leukocyte extract originating from shark spleen in order to obtain potentialized transfer factor, specifically designed for use as treatment against the disease known as asthma
06/20/2013WO2013053008A3 Molecules which bind clec9a
06/20/2013WO2013050529A3 Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders
06/20/2013WO2013045404A3 Inhibition of interleukin 1 beta for treating endometriosis
06/20/2013WO2013012770A3 Process for producing recombinant human endostatin adenovirus
06/20/2013WO2013006656A3 Appetite stimulating protein
06/20/2013WO2008045970A9 Compositions and methods of using chondroitinase abci mutants
06/20/2013US20130158510 System and method for treatment of hemorrhagic stroke
06/20/2013US20130158502 Method of inhibiting angiogenesis or invasion or formation of metastases